Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
63.86
+6.98 (12.27%)
May 6, 2026, 4:00 PM EDT - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $427.36 million as of May 6, 2026. Its market cap has increased by 62.74% in one year.
Market Cap
427.36M
Enterprise Value
287.21M
1-Year Change
62.74%
Ranking
Category
Stock Price
$63.86
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $427.36M, an increase of 54.75%. That is a compound annual growth rate of 7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 427.36M | -2.07% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 383.10M |
| X4 Pharmaceuticals | 382.77M |
| Opus Genetics | 372.72M |
| Surrozen | 368.38M |
| Avalo Therapeutics | 368.12M |
| Nautilus Biotechnology | 365.77M |
| Armata Pharmaceuticals | 360.83M |
| Palisade Bio | 356.61M |